Ilex Capital Partners UK LLP Makes New $228.21 Million Investment in The Procter & Gamble Company (NYSE:PG)

Ilex Capital Partners UK LLP purchased a new position in shares of The Procter & Gamble Company (NYSE:PG) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,406,548 shares of the company’s stock, valued at approximately $228,212,000. Procter & Gamble accounts for about 22.4% of Ilex Capital Partners UK LLP’s investment portfolio, making the stock its largest holding. Ilex Capital Partners UK LLP owned approximately 0.06% of Procter & Gamble at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Advantage Trust Co acquired a new stake in shares of Procter & Gamble during the 4th quarter valued at about $28,000. Naples Money Management LLC acquired a new stake in shares of Procter & Gamble during the 4th quarter valued at about $29,000. Transcendent Capital Group LLC acquired a new stake in shares of Procter & Gamble during the 4th quarter valued at about $31,000. Ruedi Wealth Management Inc. grew its position in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the period. Finally, Criterion Capital Advisors LLC acquired a new stake in shares of Procter & Gamble during the 4th quarter valued at about $33,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on PG shares. TD Cowen started coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 target price on the stock. Deutsche Bank Aktiengesellschaft raised their target price on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. JPMorgan Chase & Co. lifted their price objective on Procter & Gamble from $170.00 to $181.00 and gave the stock an “overweight” rating in a report on Monday, July 22nd. Argus lifted their price objective on Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Thursday, April 25th. Finally, Citigroup lifted their price objective on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Seven equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average price target of $174.29.

Procter & Gamble Trading Down 4.9 %

Shares of PG stock traded down $8.27 during trading on Tuesday, hitting $161.66. 15,745,427 shares of the stock traded hands, compared to its average volume of 6,558,331. The firm has a market capitalization of $381.54 billion, a P/E ratio of 26.42, a price-to-earnings-growth ratio of 3.18 and a beta of 0.41. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The firm’s fifty day moving average price is $166.32 and its 200-day moving average price is $161.89. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $170.92.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.49%. The ex-dividend date is Friday, July 19th. Procter & Gamble’s payout ratio is presently 65.85%.

Insider Activity

In related news, CEO Sundar G. Raman sold 31,924 shares of Procter & Gamble stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $166.95, for a total value of $5,329,711.80. Following the completion of the sale, the chief executive officer now owns 19,042 shares in the company, valued at approximately $3,179,061.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Sundar G. Raman sold 31,924 shares of Procter & Gamble stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $166.95, for a total value of $5,329,711.80. Following the completion of the sale, the chief executive officer now owns 19,042 shares in the company, valued at approximately $3,179,061.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Shailesh Jejurikar sold 31,859 shares of Procter & Gamble stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $164.90, for a total transaction of $5,253,549.10. Following the completion of the sale, the chief operating officer now owns 9,739 shares of the company’s stock, valued at approximately $1,605,961.10. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 94,320 shares of company stock valued at $15,646,323. 0.17% of the stock is currently owned by company insiders.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.